Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Authors: Konstantinos Liapis, Ioannis Kotsianidis

Source: Frontiers in Oncology, Vol 11 (2021)

Subject Terms: first-line treatment, hypomethylating agents, azacitidine (5-AzaC), decitabine (DAC), cytotoxic (or anti-neoplastic) chemotherapeutic agents, hydroxyurea (hu), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.801524/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/a66d4ae2e0b041fd9d7ea02d372b1ddb